-
China's top 20 pharmaceutical companies in the total number of applications since 2010
Time of Update: 2014-12-01
I since 2010, the top 20 enterprises in the overall number of applications have said that it is difficult to apply for queuing Which enterprises provide more workload to CDE? As shown in Table 1, Chan
-
Application for clinical application of levolacetam sustained release tablets, a class 3.1 epilepsy drug of Huahai pharmaceutical
Time of Update: 2014-12-01
According to the public information, levetiracetam is mainly used for the treatment of localized and secondary systemic epilepsy The original research drug is Belgium United Chemical Enterprise (UCB S
-
The application and production of the skin prick diagnostic kit of dust mite, a new biological drug of class 4 in Wuhan Biological Engineering Co., Ltd. was accepted
Time of Update: 2014-12-01
The company said that the product is an effective supplement to the existing product dust mite skin prick diagnostic kit, which is conducive to further enriching the product line According to the intr
-
Domestic bunanselin will be on the market soon to promote the market of psychotherapy drugs in China
Time of Update: 2014-11-30
At the same time, bunanselin orally disintegrating tablets (class 3.1) of Beijing Dezhong Wanquan Pharmaceutical Technology Development Co., Ltd were approved on November 27, 2014 - to be certified; i
-
Risperidone sustained-release microspheres of LVYE Pharmaceutical Co., Ltd. plan to complete clinical research in mid-2015
Time of Update: 2014-11-30
According to the following categories of new long-term anti schizophrenia preparations, Risperdal (Risperdal) developed and launched by Johnson & Johnson in 2003 In 2009, invega was a four week dose o
-
Jiangsu Wuzhong plans to invest 156 million yuan in the research and development project of recombinant human endostatin injection, a new biological anticancer drug
Time of Update: 2014-11-28
Jiangsu Wuzhong issued a fixed increase plan and a draft equity incentive plan at the same time today It plans to increase no more than 45.3 million shares and raise no more than 514 million yuan to n
-
Pirfenidone capsule, a new class I drug of Contini pharmaceutical, has been sold for 15 million yuan since it was put into production in March this year
Time of Update: 2014-11-27
It is understood that pirfenidone capsule is a kind of national first-class new drug developed and produced by Beijing kangdini Pharmaceutical Co., Ltd with independent intellectual property rights Si
-
Transfer of 45 million yuan of BZP to Aoxiang pharmaceutical
Time of Update: 2014-11-26
Zhengzhou University signed a patent transfer and research and development agreement with Zhejiang Aoxiang pharmaceutical industry representative Cerebrovascular disease is one of the three major dise
-
Class 3.2 ibuprofen deoxyepinephrine tablet of Kangzhi Pharmaceutical Co., Ltd. has been applied for clinical acceptance
Time of Update: 2014-11-24
Ibuprofen deoxyepinephrine tablet is a kind of over-the-counter cold medicine It is a compound cold preparation composed of antipyretic analgesic (ibuprofen) and decongestant (adrenaline oxychloride)
-
Ministry of science and technology "12th Five Year Plan" national major new drug Danlou tablet creation project officially launched
Time of Update: 2014-11-24
Song Zhiguo, chairman of Jilin kangnair Pharmaceutical Co., Ltd., introduced at the kick-off meeting that the project will take two years after its launch, and 3200 patients will be used in 66 famous
-
Kelun pharmaceutical gambles on the development of new hepatitis C drugs
Time of Update: 2014-11-24
However, the patent period of the drug in the United States is more than 20 years, and the patent authorized in China expires in 2024 In this "monopoly pricing period, the possibility of generic drugs
-
Huadong pharmaceutical acarbose chewable tablets will be approved as the exclusive dosage form in China
Time of Update: 2014-11-21
It is worth mentioning that there is no domestic enterprise that has the production approval of acarbose chewable tablets, which will become the exclusive dosage form in China after being approved Aca
-
Halomizone, a new chemical for external use of Huabang pharmaceutical, will be put into the site for inspection
Time of Update: 2014-11-21
Halometasone is used in the skin diseases that respond to corticosteroids Local application has rapid anti-inflammatory, anti allergic, antipruritic, anti exudative and anti proliferative effects At t
-
The 12th International Annual Meeting of new drug invention technology held in Suzhou
Time of Update: 2014-11-20
On November 18, 2014, the 12th International New Drug invention technology annual meeting and 2014 Suzhou International Pharmaceutical overseas high level Talents Project fair were held in Suzhou Chen
-
Clinical application for new indications of treatment of pulmonary infarction with recombinant human urokinase for injection by tisley has been accepted
Time of Update: 2014-11-19
According to the company, the application process for adding new indications is no less than that for new drugs After the clinical trial is completed, it needs to be submitted for certification, which
-
Baiai capsule, a six class new Chinese medicine for hypertension, has been approved for marketing in Yangzijiang Pharmaceutical Group
Time of Update: 2014-11-19
Baiai capsule is one of the six kinds of new drugs of traditional Chinese medicine for treating hypertension The prescription comes from volume 7-4 shengwan of woman's complete prescription written by
-
Jimincredible headquarters and new drug industrialization base project started
Time of Update: 2014-11-19
At the construction site of jimincredible headquarters and new drug industrialization base in Nanchang high tech Zone, large excavators and transport vehicles are busy In the near future, this 1050 mu
-
Application for production of recombinant human thymosin α 1, the first gene new drug in China, accepted
Time of Update: 2014-11-18
According to the public data, thymic hormone immunomodulators can regulate the development, differentiation and maturation of T-lymphocytes They are mainly used in the treatment of viral infectious di
-
Sino US Institute of brain cognitive science and brain diseases
Time of Update: 2014-11-17
It is reported that as the Sixth Research Institute of Shenzhen Advanced Institute, the main research direction of the newly established brain institute mainly includes the mechanism research of brai
-
The clinical application of class 3.1 hepatitis C drug sofibvir of Kelun Pharmaceutical Co., Ltd. was accepted
Time of Update: 2014-11-17
The drug is regarded as a breakthrough drug for the treatment of hepatitis C, and the product was approved for marketing at the end of 2013, with sales revenue of US $8.67 billion as of the third quar
